| Literature DB >> 16290148 |
Paolo Pevarello1, Daniele Fancelli, Anna Vulpetti, Raffaella Amici, Manuela Villa, Valeria Pittalà, Paola Vianello, Alexander Cameron, Marina Ciomei, Ciro Mercurio, James R Bischoff, Fulvia Roletto, Mario Varasi, Maria Gabriella Brasca.
Abstract
We have recently reported about a new class of Aurora-A inhibitors based on a bicyclic tetrahydropyrrolo[3,4-c]pyrazole scaffold. Here we describe the synthesis and early expansion of CDK2/cyclin A-E inhibitors belonging to the same chemical class. Synthesis of the compounds was accomplished using a solution-phase protocol amenable to rapid parallel expansion. Compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit CDK2-mediated tumor cell proliferation have been obtained.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16290148 DOI: 10.1016/j.bmcl.2005.10.071
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823